HPHenrique Previtalli-Silva

Henrique Previtalli-Silva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Henrique Previtalli-Silva has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Novel 1,4-Naphthoquinone-Zidovudine Hybrid: Design, Synthesis, and In Vitro Evaluation of Its Anti-Trypanosomatid and Cytotoxic Activities

    by Thiago de Souza Dias Silva, Afonso Santine M. M. Velez, Tiago Ribeiro Rodriguez, João Vitor da Costa Silva, Henrique Previtalli-Silva, Flávia de Oliveira Cardoso, Célio Geraldo Freire-De-Lima, Otávio Augusto Chaves, Debora Decote-Ricardo, Marco Edilson Freire de Lima

    This work reports the synthesis and characterization of a new molecular hybrid 4, created by combining 1,4-naphthoquinone with the drug zidovudine (AZT) through an azide-alkyne cycloaddition reaction catalyzed by Cu1+. In vitro studies assessed the anti-trypanosomatid activity of hybrid 4, along with its precursors and synthetic intermediates (1, 2, and 3), against Trypanosoma cruzi (T. cruzi Tulahuen C2C4 LacZ), Trypanosoma brucei (T. b. brucei 427), and Leishmania infantum, as well as cytotoxicity in RAW 264.7 macrophages and LLC-MK2 cells. The biological results confirm the molecular design, showing that the new hybrid is effective against both epimastigotes and amastigotes of T. cruzi (IC50 = 22.26 ± 5.78 μM and 143.10 ± 5.79 μM, respectively), with approximately 4.5-fold better capacity than AZT to inhibit the epimastigote form. Additionally, the hybrid was also active against bloodstream T. b. brucei (IC50 = 54.47 ± 6.70 μM), with approximately 2.2-fold better capacity than AZT to inhibit this parasite. It also shows low toxicity in RAW 264.7 macrophages (CC50 > 200 μM) and LLC-MK2 cells (CC50 > 200 μM). For example, hybrid 4 exhibited approximately a 6.6-fold higher SI than 1,4-naphthoquinone 1 against T. cruzi amastigotes. In this context, the work contributes to the broader knowledge base guiding the design of hybrid molecules for antiparasitic chemotherapy. It provides a rational foundation for preparing subsequent, more potent analogues.


  • Open Access

    Effect of Euterpe oleracea Mart. (Açaí) Seed Bioproducts on Trypanosoma cruzi

    by Henrique Previtalli-Silva, Daiana de Jesus Hardoim, Raphael de Lucena Banaggia, Carla J. Moragas-Tellis, Paulo Victor Ramos de Souza, Maria Dutra Behrens, Thiago de Souza Dias Silva, Kátia da Silva Calabrese, Flávia de Oliveira Cardoso

    Chagas disease remains a major public health challenge due to the limited effectiveness and considerable side effects of existing treatments, particularly during the chronic stage. Açaí (Euterpe oleracea) seeds have gained increasing attention as a source of bioactive compounds with potential therapeutic applications. In this study, hydroalcoholic extracts and solvent fractions obtained from açaí seeds were chemically characterized by ESI/MS and HPLC–MS/MS and evaluated for their cytotoxicity and antiparasitic activity against different developmental stages of Trypanosoma cruzi (Y strain). Chemical profiling revealed a predominance of phenolic compounds, particularly catechins and procyanidins, which were identified as major constituents of the hydroalcoholic extract and the ethyl acetate fraction. Cytotoxicity assays performed on murine peritoneal macrophages demonstrated low toxicity, with CC50 values exceeding 500 µg/mL for most samples, indicating a favorable in vitro safety profile. Antiparasitic assays showed weak activity against epimastigote forms; however, significant inhibitory effects were observed against bloodstream trypomastigotes, cell culture-derived trypomastigotes, and intracellular amastigotes. Notably, the hydroalcoholic extract exhibited the highest selectivity against intracellular amastigotes, with a selectivity index greater than 10, fulfilling key criteria proposed by the Drugs for Neglected Diseases initiative (DNDi) for early-stage hit compounds. Flow cytometry analysis showed that both the hydroalcoholic extract and the ethyl acetate fraction induced parasite cell death through late apoptosis-like and necrosis. Together, these findings highlight the antiparasitic potential of E. oleracea seed extracts, particularly against clinically relevant stages of T. cruzi, and support further investigation of these bioproducts as promising candidates for the development of new therapeutic strategies for Chagas disease.

  • Open Access

    Epidemiological Surveillance of Chagas Disease in Rural Communities of a Municipality in Piauí, Brazil

    by Filipe Melo da Silva, Raphael de Lucena Banaggia, Giovana Marinho Arbusti, Stefanny Nunes Fidelis, Henrique Previtalli-Silva, Lucas Almeida Zangirolami, Flávia de Oliveira Cardoso, Katia da Silva Calabrese

    Chagas disease, caused by Trypanosoma cruzi, remains a neglected tropical disease of public health importance in Latin America, particularly in rural areas. In Floriano, Piauí, Brazil, data on infection prevalence are limited. This cross-sectional population-based study assessed the seroprevalence of T. cruzi infection and analyzed sociodemographic factors associated with seropositivity among residents of 41 rural communities in Floriano. A total of 1212 individuals aged over six years were examined, revealing a seroprevalence of 3.2% (39/1212), with positive cases detected in 17 communities. Infection was significantly associated with older age (≥60 years; p < 0.0001), low educational level (p = 0.0184), retirement status (p < 0.0001), and low income (p = 0.0505). Logistic regression confirmed age as the strongest determinant of infection (OR = 7.647; 95% CI: 3.741–18.61; p < 0.0001), while higher monthly income showed a negative association with infection (OR = 0.17; 95% CI: 0.01–0.82; p = 0.086), indicating a trend toward significance. These findings highlight the persistence of T. cruzi infection in rural Floriano, predominantly among elderly individuals living in poverty. The identification of previously undiagnosed chronic cases reinforces the urgent need for targeted epidemiological surveillance, early diagnosis, and community-based health education to strengthen local control and prevention strategies.

  • Open Access

    Antioxidant and anti-inflammatory activity of Euterpe oleracea Mart. (Açaí) seed bioproducts

    by Henrique Previtalli-Silva, Daiana de Jesus Hardoim, Raphael de Lucena Banaggia, Carla Junqueira Moragas-Tellis, Maria Do Socorro dos Santos Chagas, Maria Dutra Behrens, Thiago de Souza Dias-Silva, Kátia da Silva Calabrese, Flávia de Oliveira Cardoso


  • Open Access

    In Vitro Antioxidant and Antitrypanosomal Activities of Extract and Fractions of Terminalia catappa

    by Sandra Alves de Araújo, Aldilene da Silva Lima, Cláudia Quintino da Rocha, Henrique Previtalli-Silva, Daiana de Jesus Hardoim, Noemi Nosomi Taniwaki, Kátia da Silva Calabrese, Fernando Almeida-Souza, Ana Lucia Abreu-Silva

    Chagas disease is a severe infectious and parasitic disease caused by the protozoan Trypanosoma cruzi and considered a public health problem. Chemotherapeutics are still the main means of control and treatment of the disease, however with some limitations. As an alternative treatment, plants have been pointed out due to their proven pharmacological properties. Many studies carried out with Terminalia catappa have shown several biological activities, but its effect against T. cruzi is still unknown. The objective of this work is to evaluate the therapeutic potential of extracts and fractions obtained from T. catappa on the parasite T. cruzi, in addition to analyzing its antioxidant activity. T. catappa ethyl acetate fraction were produced and submitted the chemical characterization by Liquid Chromatography Coupled to Mass Spectrometry (LC-MS). From all T. catappa extracts and fractions evaluated, the ethyl acetate and the aqueous fraction displayed the best antioxidant activity by the 2,2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging method (IC50 of 7.77 ± 1.61 and 5.26 ± 1.26 µg/mL respectively), and by ferric ion reducing (FRAP) method (687.61 ± 0.26 and 1009.32 ± 0.13 µM of Trolox equivalent/mg extract, respectively). The ethyl acetate fraction showed remarkable T. cruzi inhibitory activity with IC50 of 8.86 ± 1.13, 24.91 ± 1.15 and 85.01 ± 1.21 µg/mL against epimastigotes, trypomastigotes and intracellular amastigotes, respectively, and showed no cytotoxicity for Vero cells (CC50 > 1000 µg/mL). The treatment of epimastigotes with the ethyl acetate fraction led to drastic ultrastructural changes such as the loss of cytoplasm organelles, cell disorganization, nucleus damage and the loss of integrity of the parasite. This effect could be due to secondary compounds present in this extract, such as luteolin, kaempferol, quercetin, ellagic acid and derivatives. The ethyl acetate fraction obtained from T. catappa leaves can be an effective alternative in the treatment and control of Chagas disease, and material for further investigations.